FDA Approves GLIPIZIDE AND METFORMIN HYDROCHLORIDE — Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc. received FDA approval for ANDA088477 regarding the brand-name GLIPIZIDE AND METFORMIN HYDROCHLORIDE, expanding competition and driving potential savings for patients in the U.S. oral anti-diabetic market.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed